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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Iowa News 
• Department Efforts 
• Opioid News 
 
Iowa News 
 
National Safety Council Report 
 
On April 2, 2018, the National Safety Council released a report that shows just 13 states and 
Washington, D.C., have implemented comprehensive, proven actions to eliminate opioid 
overdoses and help protect their residents.  In the report, Iowa was identified as one of eight 
states that received a “Failing” grade, having accomplished just two of the six key actions 
identified in the report as critical and life-saving. The six key actions used for the report (and 
Iowa’s rating) are:  
 
• Mandating prescriber education (Improving) 
• Implementing opioid prescribing guidelines (Improving)  
• Integrating Prescription Drug Monitoring Programs into clinical settings (Failing)  
• Improving data collection and sharing (Failing)  
• Treating opioid overdose (Failing)  
• Increasing availability of opioid use disorder treatment (Failing)  
 
While the timing of the report doesn’t take into consideration current efforts underway the state 
is considering (House File 2237), it does reinforce the need for changes to Iowa’s approach in 
addressing the opioid epidemic.   
 
To read the report in its entirety, please click on the following link: Prescription Nation 2018 
 
Reminder: Naloxone Rebate 
 
The Iowa Attorney General has negotiated a $6.00 per dose rebate for each Amphastar 
Naloxone syringe purchased by eligible Iowa Public Entities.  This includes Iowa government 
state agencies, county and local government agencies, county and local government EMS 
providers, law enforcement agencies, and not-for-profit community agencies.     
 
The Governor’s Office of Drug Control Policy (ODCP) has agreed to collect and process rebates 
on behalf of eligible applicants in Iowa.  Rebate requests are submitted online through 
www.iowagrants.gov and are due the 23rd day following the end of each quarter (April 23, July 
23, October 23, and January 23). 
 
For questions regarding eligibility and the application process, go to the ODCP website or 
contact Dennis Wiggins at dennis.wiggins@iowa.gov.  
 
Department Efforts 
 
41st Annual Governor’s Conference on Substance Abuse: April 18-19  
 
The Governor's Conference on Substance Abuse is a statewide educational forum focused on 
substance abuse and problem gambling prevention, treatment and recovery.  The goal of the 
conference is to establish a meaningful dialogue among prevention, treatment, research, 
recovery, and policy-making professionals.  The conference provides information, resources 
and tools to facilitate strategic responses to the challenges in the field.  
 
The conference is a collaborative effort involving IDPH, service providers, and stakeholders.  In 
addition to opioids, this year’s agenda includes presentations on methamphetamines, eating 
disorders, Iowa’s medical cannabidiol law, therapy techniques for working with couples, 
recovery coaching, and other topics.  
 
For more information on the conference, click on the following link:  GCSA 
 
Opioid News 
 
American Dental Association Unveils New Policy on Opioids 
 
In what could be the first of its kind among major health care organizations, the American Dental 
Association (ADA) has announced a new policy on opioids supporting continuing education 
requirements and prescription limits. 
 
The policy states: 
 
• The ADA supports mandatory continuing education in prescribing opioids and other 
controlled substances. 
• The ADA supports statutory limits on opioid dosage and duration of no more than seven 
days for the treatment of acute pain, consistent with the Centers for Disease Control and 
Prevention evidence-based guidelines. 
• The ADA supports dentists registering with and utilizing Prescription Drug Monitoring 
Programs (PDMPs) to promote the appropriate use of opioids and deter misuse and 
abuse. 
 
“As president of the ADA, I call upon dentists everywhere to double down on their efforts to 
prevent opioids from harming our patients and their families,” said ADA President Joseph P. 
Crowley, D.D.S. “This new policy demonstrates ADA’s firm commitment to help fight the 
country’s opioid epidemic while continuing to help patients manage dental pain.” 
 
To read the entire announcement, click on the following link:  ADA  
 
